FDA Approves Ustekinumab Biosimilar Yesintek

This is the sixth ustekinumab biosimilar approval in the United States, with the drug set to launch in 2025.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-approves-ustekinumab-biosimilar-yesintek-2024a1000m0s?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost